Table 1.
Demographic, lifestyle, and laboratory variables for participants
| Variables | Placebo group* (n = 27) | Ginger group (n = 30) | P | |
|---|---|---|---|---|
| Demographic | Age (year) | 56.35 ± 7.74 | 56.40 ± 7.70 | 0.916# |
| Lifestyle | Weight (kg) | 76.35 ± 2.80 | 77.07 ± 2.10 | 0.824# |
| BMI (kg/m2) | 26.02 ± 0.88 | 27.81 ± 0.76 | 0.123# | |
| HTN | 11 (40.7) | 15 (50.0) | 0.483$ | |
| Diabetes | 12 (44.4) | 13 (43.3) | 0.933$ | |
| Smoking | 4 (14.8) | 4 (13.3) | 0.872£ | |
| Artery involvement | One coronary artery | 13 (48.1) | 21 (70.0) | 0.243$ |
| Two coronary arteries | 8 (29.6) | 5 (16.7) | ||
| Three coronary arteries | 6 (22.2) | 4 (13.3) | ||
| Laboratory | FBS (mg/dl) | 148.73 ± 15.90 | 134.57 ± 10.90 | 0.848# |
| Cholesterol (mg/dl) | 152.46 ± 4.60 | 163.27 ± 7.20 | 0.158# | |
| HDL (mg/dl) | 38.41 ± 0.86 | 39.67 ± 1.43 | 0.465# | |
| LDL (mg/dl) | 89.42 ± 4.40 | 93.29 ± 5.30 | 0.707# | |
| VLDL (mg/dl) | 26.88 ± 3.50 | 35.55 ± 2.90 | 0.007# | |
| TG (mg/dl) | 138.12 ± 16.20 | 184.50 ± 15.50 | 0.044# | |
| Lp(a) (ng/ml) | 27.63 ± 2.60 | 27.26 ± 6.70 | 0.515# | |
| CRP (µg/ml) | 1.53 ± 0.18 | 1.91 ± 0.33 | 0.991# | |
| TAC (mM) | 0.77 ± 0.53 | 0.71 ± 0.05 | 0.197# |
*
Continues and categorical variables are reported as mean ± standard deviation (SD) and absolute number (percentage), respectively
#
Independent sample t-test
$
Chi-square test
£
Fisher’s exact test
BMI: Body mass index; HTN: Hypertension, FBS: Fasting blood sugar; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; VLDL: Very-low-density lipoprotein; TG: Triglyceride; Lp(a): Lipoprotein (a); CRP: C-reactive protein; TAC: Total antioxidant capacity